Aspen Pharmacare Holdings Limited
APNHF
$7.25
$0.8813.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 613.15M | 611.73M | 634.53M | 623.91M | 564.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 613.15M | 611.73M | 634.53M | 623.91M | 564.67M |
| Cost of Revenue | 321.26M | 320.52M | 362.46M | 356.40M | 315.95M |
| Gross Profit | 291.89M | 291.21M | 272.07M | 267.52M | 248.72M |
| SG&A Expenses | 149.94M | 149.59M | 137.38M | 135.08M | 133.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 33.17M | 33.09M | -10.50M | -10.33M | 21.74M |
| Total Operating Expenses | 504.37M | 503.20M | 489.34M | 481.15M | 471.19M |
| Operating Income | 108.78M | 108.53M | 145.19M | 142.76M | 93.48M |
| Income Before Tax | 88.93M | 88.72M | 75.56M | 74.29M | 77.67M |
| Income Tax Expenses | 22.25M | 22.20M | 19.28M | 18.96M | 15.87M |
| Earnings from Continuing Operations | 66.68M | 66.52M | 56.28M | 55.34M | 61.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.68M | 66.52M | 56.28M | 55.34M | 61.81M |
| EBIT | 108.78M | 108.53M | 145.19M | 142.76M | 93.48M |
| EBITDA | 137.79M | 137.47M | 157.71M | 155.07M | 118.70M |
| EPS Basic | 0.15 | 0.15 | 0.13 | 0.12 | 0.14 |
| Normalized Basic EPS | 0.13 | 0.12 | 0.18 | 0.18 | 0.11 |
| EPS Diluted | 0.15 | 0.15 | 0.13 | 0.12 | 0.14 |
| Normalized Diluted EPS | 0.13 | 0.12 | 0.18 | 0.18 | 0.11 |
| Average Basic Shares Outstanding | 444.10M | 444.10M | 444.10M | 444.10M | 444.32M |
| Average Diluted Shares Outstanding | 444.10M | 444.10M | 444.10M | 444.10M | 444.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 67.04% | 67.04% | 0.00% | 0.00% | 65.90% |